4.58
+0(+0.00%)
Currency In USD
Address
840 Memorial Drive
Cambridge, MA 02139
United States of America
Phone
857 320 2200
Sector
Healthcare
Industry
Biotechnology
Employees
11
First IPO Date
May 09, 2019
| Name | Title | Pay | Year Born |
| Mr. William R. Hinshaw Jr. | President, Chief Executive Officer & Director | 871,677 | 1969 |
| Mr. Craig R. Jalbert CIRA | President, Chief Executive Officer, Treasurer, Secretary, Financial and Accounting Officer & Director | 0 | 1962 |
| Mr. David R. Epstein B.Sc., M.B.A. | Consultant | 228,336 | 1962 |
| Dr. Alison D. Schecter M.D. | President of Strategy & Operations | 525,531 | 1965 |
| Dr. Paul Fehlner J.D., Ph.D. | Senior Vice President, Chief Legal Officer & Corporate Secretary | 557,960 | 1964 |
| Dr. Margaret James Koziel M.D. | Senior Vice President & Chief Medical Officer | 579,769 | 1960 |
| Dr. Larry Bell | Global Head of Regulatory Affairs & Pharmacovigilance and Senior Vice President | 0 | N/A |
| Mr. Laurent Chardonnet | Consultant | 0 | 1965 |
| Mr. Robert W. Crane | Senior Vice President & Chief Financial Officer | 0 | 1959 |
| Ms. Virginia R. Dean | Senior Vice President & Chief People Officer | 0 | 1966 |
| Mr. Laurent Chardonnet M.B.A. | Consultant | 0 | 1965 |
| Marie Washburn | Vice President of Finance & Corporate Controller | 0 | N/A |
| Mr. Dan Kirby | Senior Vice President of Strategic Operations | 0 | N/A |
| Dr. Karim Azer Ph.D. | Vice President of Platform & Discovery | 0 | N/A |
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well as in Phase 2a clinical trial for Long COVID therapy for patients. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.